Results 41 to 50 of about 177,470 (196)

The HIT Network for Children and Adolescents With CNS Tumors Facilitates Improvements of Diagnostic Assessments, Multimodal Treatments, Individual Counseling, and Research in Germany, Austria, and Switzerland

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background The HIT network was established in 2000 to create a population‐based structure aiming to improve survival rates and reduce late effects for children with central nervous system (CNS) tumors by conducting comprehensive clinical trials.
Stefan Rutkowski   +59 more
wiley   +1 more source

A Comparison of Cryptography Courses

open access: yes, 2004
The author taught two courses on cryptography, one at Duke University aimed at non-mathematics majors and one at Rose-Hulman Institute of Technology aimed at mathematics and computer science majors.
Holden, Joshua
core   +1 more source

Stressful Events Reported by Childhood Cancer Survivors and Community Controls From the St. Jude Lifetime (SJLIFE) Cohort: A Mixed Method Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Characterizing stressful events reported by childhood cancer survivors experienced throughout the lifespan may help improve trauma‐informed care relevant to the survivor experience. Methods Participants included 2552 survivors (54% female; 34 years of age) and 469 community controls (62% female; 33 years of age) from the St.
Megan E. Ware   +13 more
wiley   +1 more source

Learning with Errors is easy with quantum samples

open access: yes, 2018
Learning with Errors is one of the fundamental problems in computational learning theory and has in the last years become the cornerstone of post-quantum cryptography.
Grilo, Alex B.   +2 more
core   +2 more sources

Exploring Preferences for a Digital Single‐Session Intervention for Adolescent Siblings of Youth With Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Adolescent siblings of children with cancer are at elevated risk for psychosocial problems. Unfortunately, various barriers such as limited family time and resources, conflicting schedules, and psychosocial staffing constraints at cancer centers hinder sibling access to support.
Christina M. Amaro   +10 more
wiley   +1 more source

Design and implementation of an energy-efficient Keccak algorithm ASIC

open access: yesDianzi Jishu Yingyong, 2019
The complete hardware circuit of Keccak algorithm which can support the four modes of SHA3 is designed and implemented. Based on the detailed analysis of the sponge functions and Keccak algorithm, the modular idea is used to divide the circuit structure ...
Tuo Zhao, Chen Tao, Li Wei, Nan Longmei
doaj   +1 more source

Asymmetric Cryptography

open access: yesIrish Mathematical Society Bulletin, 1988
This short survey article reviews progress in asymmetric (or public-key) cryptography. Knapsack methods are described along with the successful attacks by Shamir and others. The RSA method and certain generalisations are also considered.
openaire   +2 more sources

Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Introduction Pediatric relapsed or refractory (R/R) solid tumors carry a dismal prognosis, and postrelapse patient experiences are not well described. We present postrelapse outcomes, including number of R/R events and subsequent therapy regimens.
Matthew T. McEvoy   +5 more
wiley   +1 more source

Tomographic Quantum Cryptography

open access: yes, 2003
We present a protocol for quantum cryptography in which the data obtained for mismatched bases are used in full for the purpose of quantum state tomography.
A. Beige   +28 more
core   +1 more source

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Patients with high‐risk neuroblastoma who either are refractory to induction chemotherapy or relapse following multi‐modal treatment have a dismal prognosis. Based on data from the BEACON trial, since 2021 the UK national guidelines recommend bevacizumab, irinotecan, and temozolomide (BIT) for patients with relapsed/refractory ...
Thomas J. Jackson   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy